Synapse - Sergio Giralt

Results (349)

Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for autologous stem cell mobilization in multiple myeloma patients: An update on cost analysis study at Memorial Sloan Kettering Cancer Center

Meeting Abstract

Afifi, S.; Adel, N. G.; Duck, E.; Devlin, S. M.; Landau, H.; Lendvai, N.; Lesokhin, A. M.; Chung, D. J.; Landgren, O.; Giralt, S. A.; more...
Blood (2014)

Fulltext@MSK | Save

Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice

Journal Article

Purtill, D.; Smith, K.; Devlin, S.; Meagher, R.; Tonon, J.; Lubin, M.; Ponce, D. M.; Giralt, S.; Kernan, N. A.; Scaradavou, A.; more...
Blood (2014)

Fulltext@MSK | Save

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

Journal Article

Taur, Y.; Jenq, R. R.; Perales, M. A.; Littmann, E. R.; Morjaria, S.; Ling, L.; No, D.; Gobourne, A.; Viale, A.; Dahi, P. B.; more...
Blood (2014)

Fulltext@MSK | Save

A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma

Journal Article

Lendvai, N.; Hilden, P.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Tsakos, I.; Redling, K.; Koehne, G.; Chung, D. J.; more...
Blood (2014)

Fulltext@MSK | Save

The future of autologous stem cell transplantation in myeloma

Journal Article

Van Rhee, F.; Giralt, S.; Barlogie, B.
Blood (2014)

Fulltext@MSK | Save

Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant

Meeting Abstract

Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
Blood (2013)

Fulltext@MSK | Save

Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)

Meeting Abstract

Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
Blood (2013)

Fulltext@MSK | Save

Myeloproliferative Neoplasm Quality of Life (MPN-QOL) Study Group: Observational study of quality of life and symptomatic response in myelofibrosis patients receiving undergoing treatment with conventional therapy, the measures trial and allogeneic stem cell transplant, the symptoms trial

Meeting Abstract

Fauble, V.; Emanuel, R. M.; Geyer, H. L.; Dueck, A. C.; Kroeger, N.; Scott, B. L.; Gerds, A. T.; Popat, U. R.; Giralt, S. A.; Gupta, V.; more...
Blood (2013)

Fulltext@MSK | Save

Adverse cytogenetic abnormalities at diagnosis are the most important predictor of relapse post T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation in patients with advanced myelodysplastic syndrome (MDS)

Meeting Abstract

Tamari, R.; Jakubowski, A. A.; Papadopoulos, E. B.; Giralt, S. A.; Goldberg, J. D.; Ponce, D. M.; Sauter, C. S.; Hilden, P.; Devlin, S.; Young, J. W.; more...
Blood (2013)

Fulltext@MSK | Save

Higher stem cell dose infusion as rescue after intensive chemotherapy does not improve symptom burden in older patients with multiple myeloma and amyloidosis

Meeting Abstract

Shah, N.; Williams, L. A.; Worthing, A.; Shi, Q.; Wang, X. S.; Johnson, V.; Mendoza, T. R.; Qazilbash, M. H.; Champlin, R. E.; Giralt, S. A.; more...
Blood (2013)

Fulltext@MSK | Save

Sergio Andres Giralt

Results (349)

Meeting Abstract

Journal Article

Journal Article

Journal Article

Journal Article

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract